Your browser doesn't support javascript.
loading
Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with "difficult to treat" Gram-negative bacteria.
Bonazzetti, Cecilia; Rinaldi, Matteo; Cosentino, Federica; Gatti, Milo; Freire, Maristela Pinheiro; Mularoni, Alessandra; Clemente, Wanessa Trindade; Pierrotti, Ligia Camera; Aguado, Jose Maria; Grossi, Paolo; Pea, Federico; Viale, Pierluigi; Giannella, Maddalena.
Afiliação
  • Bonazzetti C; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
  • Rinaldi M; Infectious Diseases Unit, IRCCS Policlinico Sant'Orsola, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Cosentino F; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
  • Gatti M; Infectious Diseases Unit, IRCCS Policlinico Sant'Orsola, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Freire MP; Infectious Diseases Unit, IRCCS Policlinico Sant'Orsola, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Mularoni A; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
  • Clemente WT; Clinical Pharmacology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Pierrotti LC; Working Committee for Hospital Epidemiology and Infection Control, Hospital das Clinicas, Universidade de São Paulo, Sao Paulo, Brazil.
  • Aguado JM; Unit of Infectious Diseases, IRCCS-ISMETT Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione, Palermo, Italy.
  • Grossi P; Department of Laboratory Medicine, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Pea F; Immunosuppressed Infection Group, Divisão de Moléstias Infecciosas e Parasitárias do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil.
  • Viale P; Unit of Infectious Diseases, Hospital Universitario "12 de Octubre", Instituto de Investigación Sanitaria Hospital "12 de Octubre" (imas12), CIBERINFEC, Universidad Complutense, Madrid, Spain.
  • Giannella M; Infectious and Tropical Diseases Unit, Department of Medicine and Surgery, University of Insubria-ASST-Sette Laghi, Varese, Italy.
Transpl Infect Dis ; 26(2): e14238, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38265107
ABSTRACT

BACKGROUND:

Performance of active screening for multidrug-resistant Gram-negative bacteria (MDR-GNB) and administration of targeted antibiotic prophylaxis (TAP) in colonized patients undergoing liver (LT) and/or kidney transplantation (KT) are controversial issues.

METHODS:

Self-administered electronic cross-sectional survey disseminated from January to February 2022. Questionnaire consisted of four parts hospital/transplant program characteristics, standard screening and antibiotic prophylaxis, clinical vignettes asking for TAP in patients undergoing LT and KT with prior infection/colonization with four different MDR-GNB (extended-spectrum cephalosporin-resistant Enterobacterales [ESCR-E], carbapenem-resistant Enterobacterales [CRE], multidrug-resistant Pseudomonas aeruginosa [MDR-Pa], and carbapenem-resistant Acinetobacter baumannii [CRAb]).

RESULTS:

Fifty-five respondents participated from 14 countries, mostly infectious disease specialists (69%) with active transplant programs (>100 procedures/year for 34.5% KT and 23.6% LT), and heterogeneous local MDR-GNB prevalence from <15% (30.9%), 15%-30% (43.6%) to >30% (16.4%). The frequency of screening for ESCR-E, CRE, MDR-Pa, and CRAb was 22%, 54%, 17%, and 24% for LT, respectively, and 18%, 36%, 16%, and 11% for KT. Screening time-points were mainly at transplantation 100%, only one-third following transplantation. Screening was always based on rectal swab cultures (100%); multi-site sampling was reported in 40% of KT and 35% of LT. In LT clinical cases, 84%, 58%, 84%, and 40% of respondents reported TAP for prior infection/colonization with ESCR-E, CRE, MDR-Pa, and CRAb, respectively. In KT clinical cases, 55%, 39%, 87%, and 42% of respondents reported TAP use for prior infection/colonization with ESCR-E, CRE, MDR-Pa, and CRAb, respectively.

CONCLUSION:

There is a large heterogeneity in screening and management of MDR-GNB carriage in LT and KT.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Rim / Infecções por Bactérias Gram-Negativas Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Rim / Infecções por Bactérias Gram-Negativas Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article